Clopra and Mannitol 20% drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopra (metoclopramide hydrochloride) and Mannitol 20% (mannitol). Common drug interactions include embolism among females and haemorrhagic transformation stroke among males.

The phase IV clinical study analyzes what interactions people have when they take Clopra and Mannitol 20%. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,429 Clopra users. Check the latest studies of Clopra.

What is Mannitol 20%?

Mannitol 20% has active ingredients of mannitol. eHealthMe is studying from 79 Mannitol 20% users. Check the latest studies of Mannitol 20%.



On Oct, 03, 2025

12 people who take Clopra and Mannitol 20% together, and have interactions are studied.

Clopra and Mannitol 20% drug interactions.

What are the common drug interactions of Clopra and Mannitol 20%, by gender? *:

female:

  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  3. Amylase increased
  4. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  5. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)

male:

  1. Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia)
  2. Anticoagulation drug level above therapeutic
  3. Drug ineffective
  4. Electrocardiogram t wave amplitude decreased
  5. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Ventricular extrasystoles (premature cardiac contraction)
  9. Asthenia (weakness)
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the common drug interactions of Clopra and Mannitol 20%, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

40-49:

  1. Blood pressure immeasurable
  2. Drug ineffective
  3. Electrocardiogram t wave amplitude decreased
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Ventricular extrasystoles (premature cardiac contraction)
  7. Asthenia (weakness)
  8. Dyspnoea (difficult or laboured respiration)
  9. Pulmonary embolism (blockage of the main artery of the lung)

50-59:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Amylase increased
  3. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)

60+:

  1. Anticoagulation drug level above therapeutic
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  4. Hypovolaemic shock (shock caused by severe blood or fluid loss)

What are the existing conditions these people have? *

  1. Nausea And Vomiting: 3 people, 25.00%
  2. Oesophageal Squamous Cell Carcinoma (cancer that begins in flat cells lining the oesophagus): 2 people, 16.67%
  3. Dehydration (dryness resulting from the removal of water): 2 people, 16.67%
  4. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 16.67%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 8.33%
  6. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 8.33%
  7. Allergies: 1 person, 8.33%
  8. Cardiac Disorder: 1 person, 8.33%
  9. Cardiac Failure: 1 person, 8.33%
  10. Carnitine Deficiency: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and Mannitol 20%?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clopra and Mannitol 20%:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clopra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mannitol 20%:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mannitol 20% and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and mannitol (the active ingredients of Clopra and Mannitol 20%, respectively), and Clopra and Mannitol 20% (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: